Insulet Corporation Company Description
Insulet wants to isolate an insolent disease. The medical device company manufactures an insulin pump for people with insulin-dependent diabetes. Its disposable, waterproof product, called the OmniPod Insulin Management System, weighs a mere 1.2 ounces and adheres directly to the patient's skin, making it more discrete than most insulin infusion systems that typically clip to a belt or fit in a pocket. The company markets its products to doctors, patients, and managed care companies. Insulet was founded in 2000 and received clearance in 2005 from the FDA to market its OmniPod system. The company conducted an IPO in 2007.
View the Comprehensive Company Description for Insulet Corporation
The Company Description provides a historical perspective of Insulet Corporation's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Insulet Corporation's evolution in the marketplace.
